These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2881902)

  • 21. Toxicity of MDA (3,4-methylenedioxyamphetamine) considered for relevance to hazards of MDMA (Ecstasy) abuse.
    Davis WM; Hatoum HT; Waters IW
    Alcohol Drug Res; 1987; 7(3):123-34. PubMed ID: 2881551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of MDMA ("Ecstasy") and its optical isomers on schedule-controlled responding in mice.
    Glennon RA; Little PJ; Rosecrans JA; Yousif M
    Pharmacol Biochem Behav; 1987 Feb; 26(2):425-6. PubMed ID: 2883666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Second thoughts on 3,4-methylenedioxymethamphetamine (MDMA) neurotoxicity.
    Grob C; Bravo G; Walsh R
    Arch Gen Psychiatry; 1990 Mar; 47(3):288-9. PubMed ID: 1968330
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of MDA and MDMA ("Ecstasy") isomers in combination with pirenpirone on operant responding in mice.
    Rosecrans JA; Glennon RA
    Pharmacol Biochem Behav; 1987 Sep; 28(1):39-42. PubMed ID: 2889221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MDMA as a discriminative stimulus: isomeric comparisons.
    Schechter MD
    Pharmacol Biochem Behav; 1987 May; 27(1):41-4. PubMed ID: 2886996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of amphetamine-like designer drugs on monoaminergic systems in rat brain.
    Gibb JW; Stone DM; Stahl DC; Hanson GR
    NIDA Res Monogr; 1987; 76():316-21. PubMed ID: 2449619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain.
    Steele TD; Nichols DE; Yim GK
    Biochem Pharmacol; 1987 Jul; 36(14):2297-303. PubMed ID: 2886126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").
    McKenna DJ; Peroutka SJ
    J Neurochem; 1990 Jan; 54(1):14-22. PubMed ID: 1967141
    [No Abstract]   [Full Text] [Related]  

  • 29. Behavioral suppression following 3,4-methylenenedioxymethamphetamine.
    Kulmala HK; Boja JW; Schechter MD
    Life Sci; 1987 Sep; 41(11):1425-9. PubMed ID: 2887995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites.
    Battaglia G; Brooks BP; Kulsakdinun C; De Souza EB
    Eur J Pharmacol; 1988 Apr; 149(1-2):159-63. PubMed ID: 2899513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").
    Schechter MD
    Pharmacol Biochem Behav; 1988 Dec; 31(4):817-24. PubMed ID: 2908067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine isomers on central serotonergic, dopaminergic and nigral neurotensin systems of the rat.
    Johnson M; Letter AA; Merchant K; Hanson GR; Gibb JW
    J Pharmacol Exp Ther; 1988 Mar; 244(3):977-82. PubMed ID: 2472482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discriminative profile of MDMA.
    Schechter MD
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1533-7. PubMed ID: 2874566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term central 5-HT depletions resulting from repeated administration of MDMA enhances the effects of single administration of MDMA on schedule-controlled behavior of rats.
    Li AA; Marek GJ; Vosmer G; Seiden LS
    Pharmacol Biochem Behav; 1989 Jul; 33(3):641-8. PubMed ID: 2573905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spectral and inhibitory interactions of (+/-)-3,4-methylenedioxyamphetamine (MDA) and (+/-)-3,4-methylenedioxymethamphetamine (MDMA) with rat hepatic microsomes.
    Brady JF; Di Stefano EW; Cho AK
    Life Sci; 1986 Oct; 39(16):1457-64. PubMed ID: 2877380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methysergide potentiates the hyperactivity produced by MDMA in rats.
    Gold LH; Koob GF
    Pharmacol Biochem Behav; 1988 Mar; 29(3):645-8. PubMed ID: 2896363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulus effects of N-monoethyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDE) and N-hydroxy-1-(3,4-methylenedioxyphenyl)-2-aminopropane (N-OH MDA) in rats trained to discriminate MDMA from saline.
    Glennon RA; Misenheimer BR
    Pharmacol Biochem Behav; 1989 Aug; 33(4):909-12. PubMed ID: 2575759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3,4-Methylenedioxymethamphetamine (MDMA) and other amphetamine derivatives.
    Bost RO
    J Forensic Sci; 1988 Mar; 33(2):576-87. PubMed ID: 2897421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 'Eve' and 'Ecstasy'. A report of five deaths associated with the use of MDEA and MDMA.
    Dowling GP; McDonough ET; Bost RO
    JAMA; 1987 Mar; 257(12):1615-7. PubMed ID: 2881002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistent effects of (+/- )3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on human sleep.
    Allen RP; McCann UD; Ricaurte GA
    Sleep; 1993 Sep; 16(6):560-4. PubMed ID: 7901886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.